Mieke Versluis

1.2k citations
27 papers · 898 · h-index 16

Impact in

  • Ophthalmology top 1%
    • Ocular Oncology and Treatments
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • Immune Cell Function and Interaction

Papers in

  • Ophthalmology 16
    • Ocular Oncology and Treatments 16
  • Immunology 15
    • Immunotherapy and Immune Responses 11
    • Immune cells in cancer 5
    • Immune Cell Function and Interaction 3
Co-authors
Martine J. Jager (16 shared papers)Gregorius P. M. Luyten (11 shared papers)Pieter A. van der Velden (15 shared papers)Long V. Ly (5 shared papers)Inge H. G. Bronkhorst (5 shared papers)Ekaterina S. Jordanova (4 shared papers)Thorbald van Hall (6 shared papers)J. Vrolijk (3 shared papers)
Journals
Investigative Ophthalmology & Visual Science (5 papers)PLoS ONE (4 papers)Scientific Reports (2 papers)BMC Cancer (1 paper)Molecular Immunology (1 paper)
Partner nations
NetherlandsUnited StatesAustralia

In The Last Decade

Mieke Versluis

26 papers receiving 891 citations

Peers

Mieke Versluis
Comparison fields: 5 of 73
  • Ophthalmology 567
  • Immunology 450
  • Oncology 273
  • Radiology, Nuclear Medicine and Imaging 133
  • Cancer Research 72
Replace Long V. Ly with:
Long V. Ly Netherlands
Inge H. G. Bronkhorst Netherlands
Francesco Lanza Italy
Emma Kujala Finland
Xuefei Zhu China
Michael H. Neale United Kingdom
Hima Anbunathan United States
Tobias Schimming Germany
Burak Gümüşçü United States
Bernhard Horsthemke Germany
Mieke Versluis relative to Long V. Ly Netherlands Long V. Ly's profile →
Citations per field
00.5×1.5×1.9×
Long V. Ly · 1×
Citations per year

Countries citing papers authored by Mieke Versluis

Since Specialization
Citations

This map shows the geographic impact of Mieke Versluis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke Versluis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke Versluis more than expected).

Fields of papers citing papers by Mieke Versluis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieke Versluis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke Versluis. The network helps show where Mieke Versluis may publish in the future.

Co-authors

The 25 scholars most cited alongside Mieke Versluis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mieke Versluis Line = papers co-authored together Mieke Versluis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Detection of M2-Macrophages in Uveal Melanoma and Relation with Survival
Investigative Ophthalmology & Visual Science ·Inge H. G. Bronkhorst, Long V. Ly, Ekaterina S. Jordanova, J. Vrolijk, Mieke Versluis, Gregorius P. M. Luyten, Martine J. Jager
2010169
2
Prognostic parameters in uveal melanoma and their association with BAP1 expression
British Journal of Ophthalmology ·T. Huibertus van Essen, Sake I. van Pelt, Mieke Versluis, Inge H. G. Bronkhorst, Sjoerd G. van Duinen, Marina Marinkovic, Wilma G. M. Kroes, Claudia Ruivenkamp, Shruti Shukla, Annelies de Klein, Emine Kılıç, J. William Harbour, Gregorius P. M. Luyten, Pieter A. van der Velden, Robert M. Verdijk, Martine J. Jager
201497
3
Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma
PLoS ONE ·Mieke Versluis, Mark J. de Lange, Sake I. van Pelt, Claudia Ruivenkamp, Wilma G. M. Kroes, Jinfeng Cao, Martine J. Jager, Gré P.M. Luyten, Pieter A. van der Velden
201584
4
In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages
The Journal of Immunology ·Long V. Ly, Aabed Baghat, Mieke Versluis, Ekaterina S. Jordanova, Gregorius P. M. Luyten, Nico van Rooijen, Thorbald van Hall, Pieter A. van der Velden, Martine J. Jager
201074
5
Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes
PLoS ONE ·T. Huibertus van Essen, Sake I. van Pelt, Inge H. G. Bronkhorst, Mieke Versluis, Fariba Némati, Cécile Laurent, Gregorius P. M. Luyten, Thorbald van Hall, Peter J. van den Elsen, Pieter A. van der Velden, Didier Decaudin, Martine J. Jager
201663
6
Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy
PLoS ONE ·Marjolein Sluijter, Tetje C. van der Sluis, Pieter A. van der Velden, Mieke Versluis, Brian L. West, Sjoerd H. van der Burg, Thorbald van Hall
201451
7
Inflammatory Cytokines in Eyes with Uveal Melanoma and Relation with Macrophage Infiltration
Investigative Ophthalmology & Visual Science ·Long V. Ly, Inge H. G. Bronkhorst, Els van Beelen, J. Vrolijk, Andrew W. Taylor, Mieke Versluis, Gregorius P. M. Luyten, Martine J. Jager
201044
8
Peptide Vaccination after T-Cell Transfer Causes Massive Clonal Expansion, Tumor Eradication, and Manageable Cytokine Storm
Cancer Research ·Long V. Ly, Marjolein Sluijter, Mieke Versluis, Gré P.M. Luyten, Sjoerd H. van der Burg, Cornelis J.M. Melief, Martine J. Jager, Thorbald van Hall
201040
9
Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma
Oncotarget ·Mark J. de Lange, Sake I. van Pelt, Mieke Versluis, Ekaterina S. Jordanova, Wilma G. M. Kroes, Claudia Ruivenkamp, Sjoerd H. van der Burg, Gregorius P. M. Luyten, Thorbald van Hall, Martine J. Jager, Pieter A. van der Velden
201540
10
Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
PLoS ONE ·Mark J. de Lange, Lubna Razzaq, Mieke Versluis, Sven Verlinde, Mehmet Doğrusöz, Stefan Böhringer, Marina Marinkovic, Gregorius P. M. Luyten, R. J. W. De Keizer, Frank R. de Gruijl, Martine J. Jager, Pieter A. van der Velden
201534
11
Digital PCR-Based T-cell Quantification–Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma
Molecular Cancer Research ·Mark J. de Lange, Rogier J. Nell, Rajshri N. Lalai, Mieke Versluis, Ekaterina S. Jordanova, Gré P.M. Luyten, Martine J. Jager, Sjoerd H. van der Burg, Willem H. Zoutman, Thorbald van Hall, Pieter A. van der Velden
201833
12
Bevacizumab and intraocular tumors: an intriguing paradox.
PubMed ·Mariam el Filali, Long V. Ly, Gregorius P. M. Luyten, Mieke Versluis, Hans E. Grossniklaus, Pieter A. van der Velden, Martine J. Jager
201227
13
Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma
BMC Cancer ·Rogier J. Nell, Nino V. Menger, Mieke Versluis, Gregorius P. M. Luyten, Robert M. Verdijk, Michele C. Madigan, Martine J. Jager, Pieter A. van der Velden
202123
14
Radiation Treatment Affects Chromosome Testing in Uveal Melanoma
Investigative Ophthalmology & Visual Science ·Mehmet Doğrusöz, Wilma G. M. Kroes, Sjoerd G. van Duinen, Carien L. Creutzberg, Mieke Versluis, Jaco C. Bleeker, Marina Marinkovic, Gregorius P. M. Luyten, Martine J. Jager
201522
15
Role of Adenosine Receptors in the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Drugs in R&D ·Maarten van den Berge, Machteld N. Hylkema, Mieke Versluis, Dirkje S. Postma
200718
16
Accurate Quantification of T Cells by Measuring Loss of Germline T-Cell Receptor Loci with Generic Single Duplex Droplet Digital PCR Assays
Journal of Molecular Diagnostics ·Willem H. Zoutman, Rogier J. Nell, Mieke Versluis, Debby van Steenderen, Rajshri N. Lalai, Jacoba J. Out‐Luiting, Mark J. de Lange, Maarten H. Vermeer, Anton W. Langerak, Pieter A. van der Velden
201616
17
Culturing Uveal Melanoma Cells
Ocular Oncology and Pathology ·Martina Angi, Mieke Versluis, Helen Kalirai
201514
18
Quantification of DNA methylation independent of sodium bisulfite conversion using methylation‐sensitive restriction enzymes and digital PCR
Human Mutation ·Rogier J. Nell, Debby van Steenderen, Nino V. Menger, Thomas J. Weitering, Mieke Versluis, Pieter A. van der Velden
202014
19
Analysis of Inflammatory Cells in Uveal Melanoma after Prior Irradiation
Investigative Ophthalmology & Visual Science ·T. H. Khanh Vu, Inge H. G. Bronkhorst, Mieke Versluis, Marina Marinkovic, Sjoerd G. van Duinen, J. Vrolijk, Gregorius P. M. Luyten, Martine J. Jager
20129
20
Effects of IL-4 and IL-13 on adenosine receptor expression and responsiveness of the human mast cell line 1
International Immunopharmacology ·Mieke Versluis, Dirkje S. Postma, Wim Timens, Machteld N. Hylkema
20088

About Mieke Versluis

Mieke Versluis is a scholar working on Ophthalmology, Immunology, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 898 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (16 papers), Immunotherapy and Immune Responses (11 papers), Immune cells in cancer (5 papers), Retinal Development and Disorders (5 papers), CAR-T cell therapy research (4 papers), Cutaneous Melanoma Detection and Management (3 papers), Immune Cell Function and Interaction (3 papers) and Corneal Surgery and Treatments (2 papers). The work is most often cited by research in Ophthalmology (567 citations), Immunology (450 citations), Oncology (273 citations), Radiology, Nuclear Medicine and Imaging (133 citations) and Cancer Research (72 citations). Mieke Versluis has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Martine J. Jager, Gregorius P. M. Luyten, Pieter A. van der Velden, Long V. Ly, Inge H. G. Bronkhorst, Ekaterina S. Jordanova, Thorbald van Hall, J. Vrolijk, Wilma G. M. Kroes and Mark J. de Lange. Their work appears in journals such as Investigative Ophthalmology & Visual Science, PLoS ONE, Scientific Reports, BMC Cancer and Molecular Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Long V. LyBreakdown of academic impact, for papers by Inge H. G. BronkhorstBreakdown of academic impact, for papers by Francesco LanzaBreakdown of academic impact, for papers by Emma KujalaBreakdown of academic impact, for papers by Xuefei ZhuBreakdown of academic impact, for papers by Michael H. NealeBreakdown of academic impact, for papers by Hima AnbunathanBreakdown of academic impact, for papers by Tobias SchimmingBreakdown of academic impact, for papers by Burak GümüşçüBreakdown of academic impact, for papers by Bernhard Horsthemke